cheironinitiative2022幎4æ21æ¥èªäºæé: 5å[è«æè³]åæ¬ æ ¶å/æµæŸå»ç§å€§åŠéå±ç é¢ç®èç§åŠè¬åº§Keiko Sakamoto, M.D.[åé2ïŒå ç«ã¢ã¬ã«ã®ãŒ]Disruption of the endopeptidase ADAM10-Notch signaling axis leads to skin dysbiosis and innate lymphoid cell-mediated hair follicle destruction (ADAM10-Notch ã·ã°ããªã³ã°ãæ ãæ¯å¢çŽ°èå¢ã®æåžžæ§ã®ç¶æãšãã®ç Žç¶»ã«ããççæ§æ¯å¢ç Žå£)Immunity, September 2021æŠèŠ ç®èã¯åžžåšçŽ°èå¢ãšå ç«çŽ°èãæ»é²ãç¹°ãåºããçäœæå€å±€ã®å ç«ããªã¢ã§ãããç¹ã«ãæ¯å¢ã¯å ç«çŽ°èã现èå¢ããã³å¹¹çŽ°èã亀差ããããã·ã§ã§ããã宿䞻ãšåŸ®çç©ã®å ±çãå¯èœã«ããã¡ã«ããºã ãååšããããšãäºæ³ãããããŸãããã®å ±çé¢ä¿ã¯å®åžžç¶æ ã ãã§ãªããççæã«ãç¶æãããªããã°ãªããªããèééåèçœåè§£é µçŽ ã§ããADAM10ã¯æ¯å¢ã®çºçã«å¿ èŠã§ããã现èæ¯çŽ ã®å容äœãšããŠå®¿äž»å ç«ã«è²¢ç®ããããšãããæ¯å¢çŽ°èå¢ã®å¶åŸ¡ã«é¢ãã£ãŠããããšãäºæ³ããããŠã£ã«ã¹ææã§ã¯Iåã€ã³ã¿ãŒãã§ãã³ïŒIFNïŒã宿䞻å ç«ã掻æ§åãããäžæ¹ã§ãå šèº«æ§ãšãªããããŒãã¹ãè±æ¯çãªã©ã®èªå·±å ç«çŸæ£ãèªçºããããšãç¥ãããŠãããæ¬è«æã§ã¯ããŠã£ã«ã¹å ç«çºåæã®çµç¹æåžžæ§ã®å¶åŸ¡ã¡ã«ããºã ãæããã«ããããã«ãIåIFNåå¿æ§ã®æ¯å¢äžéšã®çŽ°èããADAM10ãèªå°æ¬ 倱ãããããŠã¹ã¢ãã«ãäžå¿ã«è§£æããã ãã®çµæãïŒïŒIåIFNåå¿æ§ã®æ¯å¢äžéšçŽ°èã¯ADAM10-Notchã·ã°ããªã³ã°ãä»ããŠæèããããã®Î²-defensin-6ãç£çããæ¯å¢çŽ°èå¢ãå¶åŸ¡ããŠããããšãïŒïŒãããã®çŽ°èããADAM10ãæ¬ å€±ããããšãããæ¯å¢çŽ°èå¢ãã³ãªããã¯ããªãŠã å±ã«æ¯é ãããããšãïŒïŒãã®çµæãèªç¶ãªã³ãçã§ããILC2ãççãæ¹èµ·ããæ¯å¢ã®çŽ°èæ»ãèªå°ãããããšãïŒïŒæçµçã«ã¯å¹¹çŽ°èé åã§ãããã«ãžã倱ãããããšã«ãããäžå¯éæ§ã®è±æ¯ãèµ·ããããšãã瀺ããã宿䞻ãšåŸ®çç©ã®å ±çã«ã¯ADAM10-Notchã·ã°ããªã³ã°ãéèŠã§ãããããããé»å®³ãããããšã«ããããã®å ±çé¢ä¿ãç Žç¶»ãã幹现èç¶æã«æ¯éããããããšãæããã«ããããããã®ç¥èŠã¯ççäžã«ãããçµç¹ã®æåžžæ§ãç¶æããããã«éèŠãªã¡ã«ããºã ã§ãããšèããŠãããåè³è ã®ã³ã¡ã³ã ãã®åºŠã¯U J Aè«æè³ãããã ããŸããŠã倧å€å æ ã«æã£ãŠãããŸããå¿åãå§ããŠãã ãã£ãæµæŸå»ç§å€§åŠç®èç§åŠè¬åº§ã®æ¬ç°å²ä¹ææãã¯ãããè«æè³ã®å¯©æ»ãããŠãããã ããå çæ¹ã«æè¬ç³ãäžããŸãã審æ»å¡ã®ã³ã¡ã³ã森ç°è±æ å ç: æ¬ç 究ã§ã¯ç®èã«ããã宿䞻ãšåŸ®çç©å¢ã«éèŠãªã¡ã«ããºã ãæããã«ãããšå ±ã«ããã®ã·ã¹ãã ã倱ãããéã«ã埮çç©å¢ã®ç Žç¶»ã«ããäžå¯éçãªè±æ¯ã«è³ãã¡ã«ããºã ãæããã«ããŠããŸãã宿䞻ãšåŸ®çç©ã®å ±çãçäœé²åŸ¡æ©æ§ãžã®ç解ãæ·±ãŸããšå ±ã«ãäžå¯éçãªè±æ¯ã«å¯Ÿããæ°ããªæ²»çæ³ã®éçºã«ã€ãªããå¯èœæ§ããããŸããåŸè€ 矩幞 å ç: çäœã®ä»£è¡šçãªé²åŸ¡ããªã¢ã§ããç®èã«ãããŠããŠã€ã«ã¹ææã«ãã£ãŠèªå°ãããIFNå¿çæã«ãããæ¯å¢äžéšçŽ°èã®ADAM10ã®åœ¹å²ã解æããç 究ã§ããin vitroãin vivoã®å®éšç³»ãé§äœ¿ããåžžåšçŽ°èãå ç«çŽ°èã幹现èã®çžäºäœçšããã³æåžžæ§ç¶ææ©æ§ã®è©³çŽ°ãæããã«ããŠããã極ããŠã¬ãã«ã®é«ãç 究å 容ãšãªã£ãŠããŸããçŸåšãCOVID-19ãäžçäžã§è延ããŠããããŠã€ã«ã¹ææã«äŒŽãIFNã®çäœã«ããã圱é¿ã«ã€ããŠãäžççã«æ³šç®ãããŠãããæ¬ç 究ææãåºã«è±æ¯ãªã©æ§ã ãªç®èçŸæ£ã®æ°èŠæ²»çæ³ã®éçºã«ç¹ããããšãæåŸ ãããŸããå°é寺淳 å ç: è¿å¹Žæ³šç®ãããŠããtype I IFNãšãè±æ¯ã®é¢é£æ§ãæããã«ããç»æçãªè«æã ãšæããŸããããªãå€ãã®å®éšããŒã¿ã瀺ããã詳现ãªæ¡ä»¶æ€èšã«ã€ããŠãèšèŒããããªã©ãèè ã®å°œåãäŒãã£ãŠããŸããæ§ã ãªKOããŠã¹ããã·ãŒã¯ãšã³ã¹æè¡ãé§äœ¿ããŠå®æ床ã®é«ãè«æã§ãããšã®å°è±¡ãæã¡ãŸãããMx1-creãšRosa-YFPãçšããå®éšç³»ã¯ã¯ã¬ããŒã§ããå人çã«ã¯ãæè¿è±æ¯ãæ°ã«ãªã幎霢ãè¿ããä»åã®çºèŠãæå¹ãªè±æ¯æ²»çæ³ã«ã€ãªããããšãæåŸ ããŸãããšããœãŒã ç§ã¯æž¡ç±³åãŸã§ç®èç§èšåºå»ãšããŠåããŠãããå šãåºç€ç 究ã®çµéšããããŸããã§ããã埪ç°åšå ç§å»ã§ãã䞻人ã®ã¢ã¡ãªã«çåŠã決ãŸã£ãæãç§èªèº«ãäœãææ矩ãªæéãéãããããšæããæµæŸå»ç§å€§åŠç®èç§åŠè¬åº§ã®æžåæ°æš¹åææã«ãçžè«ããŠãN I Hã®æ°žå°Ÿåä»å士ãã玹ä»ããã ããŸãããä»æãã°ãããããã®äœ¿ãæ¹ãããããªãã©çŽ 人ãåãå ¥ããŠãã ãã£ãæ°žå°Ÿå çã«ã¯æè¬ã®èšèããããŸããããŸãã¯ãã©ã³ãã£ã¢ãšããŠç¡çµŠã§ã©ãã®ä»äºããããŠããã ããïŒå¹ŽåŸã«ã¯ïŒå°ãèªããããŠïŒïŒvisiting fellowãšããŠéã£ãŠããã ããããšãšãªããŸãããç§ã®ç 究ãããžã§ã¯ãã¯ãæãŠã€ã«ã¹å ç«ãå¢åŒ·ããããšäžå¯éæ§ã®è±æ¯ãèµ·ããããŠã¹ã®åå ã解æããããšã§ãããæ¯æ¥ããŠã¹ãšå¯Ÿè©±ããªãã芳å¯ããŠããäžã§ãç®èç§å»ãšããŠã®çŒãéåžžã«åœ¹ã«ç«ã¡ãŸãããããŠã¹ã®ç®èè¡šé¢ã«çœãå°ããªå¡ãä»çããŠããã®ãèŠã€ãããã£ã¹ãã€ãªãŒã·ã¹ïŒçŽ°èå¢ã®åãïŒã®çºèŠã®ãã£ãããšãªãããããå¥æ©ã«æ¯ã®ççæ§ç Žå£ãèµ·ããŠããããšã蚌æããŸãããã³ããçŠã«ããèŠå¶ãããin vivoã®å®éšãè¡ãã®ã倧å€ã§ãããããªããšãããåãããšãã§ããŸãããïŒïŒç 究è ãç®æãããã£ãã ç¹ã«ç 究è ãç®æããŠããããã§ã¯ãããŸãããããããããªãçžã«æµãŸããŠåºç€ç 究ãè¡ãããšãã§ããŸãããããããã£ããã«ãæ¥æ¬ã§ãèªåã®ç 究ãšèšåºãæ·±ããŠãããããšæããŸããïŒïŒçŸåšã®å°éåéã«é²ãã çç± ç®èç§ã®èšåºå»ãªã®ã§ãå°ãã§ãç æ°ã®ç解ã«åœ¹ç«ã€ç 究ãããããšæããŸãããïŒïŒãã®ç 究ã®å°æ¥æ§ ä»åçºè¡šããããŠã¹ã¢ãã«ã¯ã人ã§ã¯ç¢çæ§è±æ¯ãšããç æ°ã®éšé¡ã«å ¥ããŸããç¢çæ§è±æ¯ã¯çŸåšæ²»çæ³ããªããä»å瀺ãããããªççãæ²»çæšçãšãªãããšãæåŸ ããŠããŸãã
Keiko Sakamoto, M.D.[åé2ïŒå ç«ã¢ã¬ã«ã®ãŒ]Disruption of the endopeptidase ADAM10-Notch signaling axis leads to skin dysbiosis and innate lymphoid cell-mediated hair follicle destruction (ADAM10-Notch ã·ã°ããªã³ã°ãæ ãæ¯å¢çŽ°èå¢ã®æåžžæ§ã®ç¶æãšãã®ç Žç¶»ã«ããççæ§æ¯å¢ç Žå£)Immunity, September 2021æŠèŠ ç®èã¯åžžåšçŽ°èå¢ãšå ç«çŽ°èãæ»é²ãç¹°ãåºããçäœæå€å±€ã®å ç«ããªã¢ã§ãããç¹ã«ãæ¯å¢ã¯å ç«çŽ°èã现èå¢ããã³å¹¹çŽ°èã亀差ããããã·ã§ã§ããã宿䞻ãšåŸ®çç©ã®å ±çãå¯èœã«ããã¡ã«ããºã ãååšããããšãäºæ³ãããããŸãããã®å ±çé¢ä¿ã¯å®åžžç¶æ ã ãã§ãªããççæã«ãç¶æãããªããã°ãªããªããèééåèçœåè§£é µçŽ ã§ããADAM10ã¯æ¯å¢ã®çºçã«å¿ èŠã§ããã现èæ¯çŽ ã®å容äœãšããŠå®¿äž»å ç«ã«è²¢ç®ããããšãããæ¯å¢çŽ°èå¢ã®å¶åŸ¡ã«é¢ãã£ãŠããããšãäºæ³ããããŠã£ã«ã¹ææã§ã¯Iåã€ã³ã¿ãŒãã§ãã³ïŒIFNïŒã宿䞻å ç«ã掻æ§åãããäžæ¹ã§ãå šèº«æ§ãšãªããããŒãã¹ãè±æ¯çãªã©ã®èªå·±å ç«çŸæ£ãèªçºããããšãç¥ãããŠãããæ¬è«æã§ã¯ããŠã£ã«ã¹å ç«çºåæã®çµç¹æåžžæ§ã®å¶åŸ¡ã¡ã«ããºã ãæããã«ããããã«ãIåIFNåå¿æ§ã®æ¯å¢äžéšã®çŽ°èããADAM10ãèªå°æ¬ 倱ãããããŠã¹ã¢ãã«ãäžå¿ã«è§£æããã ãã®çµæãïŒïŒIåIFNåå¿æ§ã®æ¯å¢äžéšçŽ°èã¯ADAM10-Notchã·ã°ããªã³ã°ãä»ããŠæèããããã®Î²-defensin-6ãç£çããæ¯å¢çŽ°èå¢ãå¶åŸ¡ããŠããããšãïŒïŒãããã®çŽ°èããADAM10ãæ¬ å€±ããããšãããæ¯å¢çŽ°èå¢ãã³ãªããã¯ããªãŠã å±ã«æ¯é ãããããšãïŒïŒãã®çµæãèªç¶ãªã³ãçã§ããILC2ãççãæ¹èµ·ããæ¯å¢ã®çŽ°èæ»ãèªå°ãããããšãïŒïŒæçµçã«ã¯å¹¹çŽ°èé åã§ãããã«ãžã倱ãããããšã«ãããäžå¯éæ§ã®è±æ¯ãèµ·ããããšãã瀺ããã宿䞻ãšåŸ®çç©ã®å ±çã«ã¯ADAM10-Notchã·ã°ããªã³ã°ãéèŠã§ãããããããé»å®³ãããããšã«ããããã®å ±çé¢ä¿ãç Žç¶»ãã幹现èç¶æã«æ¯éããããããšãæããã«ããããããã®ç¥èŠã¯ççäžã«ãããçµç¹ã®æåžžæ§ãç¶æããããã«éèŠãªã¡ã«ããºã ã§ãããšèããŠãããåè³è ã®ã³ã¡ã³ã ãã®åºŠã¯U J Aè«æè³ãããã ããŸããŠã倧å€å æ ã«æã£ãŠãããŸããå¿åãå§ããŠãã ãã£ãæµæŸå»ç§å€§åŠç®èç§åŠè¬åº§ã®æ¬ç°å²ä¹ææãã¯ãããè«æè³ã®å¯©æ»ãããŠãããã ããå çæ¹ã«æè¬ç³ãäžããŸãã審æ»å¡ã®ã³ã¡ã³ã森ç°è±æ å ç: æ¬ç 究ã§ã¯ç®èã«ããã宿䞻ãšåŸ®çç©å¢ã«éèŠãªã¡ã«ããºã ãæããã«ãããšå ±ã«ããã®ã·ã¹ãã ã倱ãããéã«ã埮çç©å¢ã®ç Žç¶»ã«ããäžå¯éçãªè±æ¯ã«è³ãã¡ã«ããºã ãæããã«ããŠããŸãã宿䞻ãšåŸ®çç©ã®å ±çãçäœé²åŸ¡æ©æ§ãžã®ç解ãæ·±ãŸããšå ±ã«ãäžå¯éçãªè±æ¯ã«å¯Ÿããæ°ããªæ²»çæ³ã®éçºã«ã€ãªããå¯èœæ§ããããŸããåŸè€ 矩幞 å ç: çäœã®ä»£è¡šçãªé²åŸ¡ããªã¢ã§ããç®èã«ãããŠããŠã€ã«ã¹ææã«ãã£ãŠèªå°ãããIFNå¿çæã«ãããæ¯å¢äžéšçŽ°èã®ADAM10ã®åœ¹å²ã解æããç 究ã§ããin vitroãin vivoã®å®éšç³»ãé§äœ¿ããåžžåšçŽ°èãå ç«çŽ°èã幹现èã®çžäºäœçšããã³æåžžæ§ç¶ææ©æ§ã®è©³çŽ°ãæããã«ããŠããã極ããŠã¬ãã«ã®é«ãç 究å 容ãšãªã£ãŠããŸããçŸåšãCOVID-19ãäžçäžã§è延ããŠããããŠã€ã«ã¹ææã«äŒŽãIFNã®çäœã«ããã圱é¿ã«ã€ããŠãäžççã«æ³šç®ãããŠãããæ¬ç 究ææãåºã«è±æ¯ãªã©æ§ã ãªç®èçŸæ£ã®æ°èŠæ²»çæ³ã®éçºã«ç¹ããããšãæåŸ ãããŸããå°é寺淳 å ç: è¿å¹Žæ³šç®ãããŠããtype I IFNãšãè±æ¯ã®é¢é£æ§ãæããã«ããç»æçãªè«æã ãšæããŸããããªãå€ãã®å®éšããŒã¿ã瀺ããã詳现ãªæ¡ä»¶æ€èšã«ã€ããŠãèšèŒããããªã©ãèè ã®å°œåãäŒãã£ãŠããŸããæ§ã ãªKOããŠã¹ããã·ãŒã¯ãšã³ã¹æè¡ãé§äœ¿ããŠå®æ床ã®é«ãè«æã§ãããšã®å°è±¡ãæã¡ãŸãããMx1-creãšRosa-YFPãçšããå®éšç³»ã¯ã¯ã¬ããŒã§ããå人çã«ã¯ãæè¿è±æ¯ãæ°ã«ãªã幎霢ãè¿ããä»åã®çºèŠãæå¹ãªè±æ¯æ²»çæ³ã«ã€ãªããããšãæåŸ ããŸãããšããœãŒã ç§ã¯æž¡ç±³åãŸã§ç®èç§èšåºå»ãšããŠåããŠãããå šãåºç€ç 究ã®çµéšããããŸããã§ããã埪ç°åšå ç§å»ã§ãã䞻人ã®ã¢ã¡ãªã«çåŠã決ãŸã£ãæãç§èªèº«ãäœãææ矩ãªæéãéãããããšæããæµæŸå»ç§å€§åŠç®èç§åŠè¬åº§ã®æžåæ°æš¹åææã«ãçžè«ããŠãN I Hã®æ°žå°Ÿåä»å士ãã玹ä»ããã ããŸãããä»æãã°ãããããã®äœ¿ãæ¹ãããããªãã©çŽ 人ãåãå ¥ããŠãã ãã£ãæ°žå°Ÿå çã«ã¯æè¬ã®èšèããããŸããããŸãã¯ãã©ã³ãã£ã¢ãšããŠç¡çµŠã§ã©ãã®ä»äºããããŠããã ããïŒå¹ŽåŸã«ã¯ïŒå°ãèªããããŠïŒïŒvisiting fellowãšããŠéã£ãŠããã ããããšãšãªããŸãããç§ã®ç 究ãããžã§ã¯ãã¯ãæãŠã€ã«ã¹å ç«ãå¢åŒ·ããããšäžå¯éæ§ã®è±æ¯ãèµ·ããããŠã¹ã®åå ã解æããããšã§ãããæ¯æ¥ããŠã¹ãšå¯Ÿè©±ããªãã芳å¯ããŠããäžã§ãç®èç§å»ãšããŠã®çŒãéåžžã«åœ¹ã«ç«ã¡ãŸãããããŠã¹ã®ç®èè¡šé¢ã«çœãå°ããªå¡ãä»çããŠããã®ãèŠã€ãããã£ã¹ãã€ãªãŒã·ã¹ïŒçŽ°èå¢ã®åãïŒã®çºèŠã®ãã£ãããšãªãããããå¥æ©ã«æ¯ã®ççæ§ç Žå£ãèµ·ããŠããããšã蚌æããŸãããã³ããçŠã«ããèŠå¶ãããin vivoã®å®éšãè¡ãã®ã倧å€ã§ãããããªããšãããåãããšãã§ããŸãããïŒïŒç 究è ãç®æãããã£ãã ç¹ã«ç 究è ãç®æããŠããããã§ã¯ãããŸãããããããããªãçžã«æµãŸããŠåºç€ç 究ãè¡ãããšãã§ããŸãããããããã£ããã«ãæ¥æ¬ã§ãèªåã®ç 究ãšèšåºãæ·±ããŠãããããšæããŸããïŒïŒçŸåšã®å°éåéã«é²ãã çç± ç®èç§ã®èšåºå»ãªã®ã§ãå°ãã§ãç æ°ã®ç解ã«åœ¹ç«ã€ç 究ãããããšæããŸãããïŒïŒãã®ç 究ã®å°æ¥æ§ ä»åçºè¡šããããŠã¹ã¢ãã«ã¯ã人ã§ã¯ç¢çæ§è±æ¯ãšããç æ°ã®éšé¡ã«å ¥ããŸããç¢çæ§è±æ¯ã¯çŸåšæ²»çæ³ããªããä»å瀺ãããããªççãæ²»çæšçãšãªãããšãæåŸ ããŠããŸãã